American Journal of Nephrology· 2017Q1· Review

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

Rimda Wanchoo, Sabine Karam, Nupur N. Uppal, Valerie S. Barta et al.

15,288citations
Q1SCImago
2017year

Short summary

Immune checkpoint inhibitors (ICIs) like anti-CTLA-4 and anti-PD-1, while revolutionizing cancer treatment, can cause significant kidney toxicities, with recent studies suggesting incidence rates of 9.9-29%.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Oncology

OncologyMedicine